An Approach to the Design of Receptor-Type-Selective Non-Peptide Antagonists of Peptidergic Receptors: δ Opioid Antagonists

Journal of Medicinal Chemistry

Volumn 34, Issue 6, 1991, Pages 1757-1762

  Portoghese, Philip S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; ENKEPHALIN DERIVATIVE; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALTREXONE; NALTRINDOLE; OPIATE ANTAGONIST;

ANIMAL TISSUE; DRUG RESEARCH; GUINEA PIG; ILEUM; MOUSE; NOTE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VAS DEFERENS;

AMINO ACID SEQUENCE; DRUG DESIGN; ENKEPHALINS; INDOLES; MOLECULAR SEQUENCE DATA; MORPHINANS; PROTEIN CONFORMATION; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025733775     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00110a001     Document Type: Article

References (29)

1. Morgan, B. A.; Gainor, J. A. Approaches to the Discovery of Non-Peptide Ligands for Peptide Receptors and Peptidases. Anna. Rep. Med. Chem. 1989, 24, 243-252.
2. Yamashiro, D.; Li, C. H. β-Endorphin: Structure and Activity. In The Peptides; Udenfriend, S., Meienhofer, J., Eds.; Academic Press: New York, 1984; Vol. 6, pp 191-217.
3. Portoghese, P. S. A New Concept on the Mode of Interaction of Narcotic Analgesics with Receptors. J. Med. Chem. 1965, 8, 609-616.
4. Portoghese, P. S. Stereochemical Factors and Receptor Interactions Associated with Narcotic Analgesics. J. Pharm. Sci. 1966, 55, 865-887.
5. Martin, W. R. Opioid Antagonists. Pharmacol. Rev. 1967, 19, 463-521.
6. Takemori, A. E.; Kupferberg, H. J.; Miller, J. W. Quantitative Studies of the Antagonism of Morphine by Nalorphine and Naloxone. J. Pharmacol. Exp. Ther. 1969, 169, 39-45.
7. Smite, S. E.; Takemori, A. E. Quantitative Studies on the Antagonism of Naloxone and Some Narcotic and Narcotic-Antagonist Analgesics. Br. J. Pharmacol. 1970, 39, 627-638.
8. Martin, W. R.; Eades, C. G.; Thompson, J. A.; Huppler, R. E.; Gilbert, P. E. The Effects of Morphine- and Nalorphine-Like Drugs in the Nondependent and Morphine-Dependent Chronic Spinal Dog. J. Pharmacol. Exp. Ther. 1976, 197, 517-533.
9. Gilbert, P. E.; Martin, W. R. The Effects of Morphine and Nalorphine-Like Drugs in the Nondependent, Morphine-Dependent and Cyclazocine-Dependent Chronic Spinal Dog. J. Pharmacol. Exp. Ther. 1976, 198, 66-82.
10. Lord, J. A. H.; Waterfîeld, A. A.; Hughes, J.; Kosterlitz, H. W. Endogenous Opioid Peptides: Multiple Agonists and Receptors. Nature 1977, 267, 495-499.
11. Herz, A. The Multiplicity of Opioid Receptors and Their Functional Significance. In Trends in Medicinal Chemistry; Mutschler, E., Wintefeldt, E., Eds., VCH Verlagsgesellschaft: Weinheim, 1987; pp 337-350.
12. Zimmerman, D. M.; Leander, J. D. Selective Opioid Receptor Agonists and Antagonists: Research Tools and Potential Therapeutic Agents. J. Med. Chem. 1990, 33, 895-902.
13. Olson, G. A.; Olson, R. D.; Kastin, A. J. Endogenous Opiates: 1987. Peptides 1989, 10, 205-236.
14. Schwyzer, R. ACTH: A Short Introductory Review. Ann. N. Y. Acad. Sci. 1977, 297, 3-26.
15. Chavkin, C.; Goldstein, A. Specific Receptor for the Opioid Peptide Dynorphin. Proc. Natl. Acad. Sci. U. S. A. 1981, 78, 6543-6547.
16. Lipkowski, A. W.; Tam, S. W.; Portoghese, P. S. Peptides as Receptor Selectivity Modulators of Opiate Pharmacophores. J. Med. Chem. 1986, 29, 1222-1225.
17. Hruby, V. J.; Gehrig, C. A. Recent Developments in the Design of Receptor Specific Opioid Peptides. Med. Res. Rev. 1989, 9, 343-401.
18. Portoghese, P. S.; Sultana, M.; Takemori, A. E. Design of Peptidomimetic 6 Opioid Receptor Antagonists Using the Message-Address Concept. J. Med. Chem. 1990, 33, 1714-1720.
19. Portoghese, P. S.; Sultana, M.; Nagase, H.; Takemori, A. E. Application of the Message-Address Concept in the Design of Highly Potent and Selective Non-Peptide S Opioid Receptor Antagonists. J. Med. Chem. 1988, 31, 281-282.
20. Portoghese, P. S.; Sultana, M.; Takemori, A. E. Naltrindole, a Highly Potent Non-Peptide 6 Opioid Receptor Antagonist. Eur. J. Pharmacol. 1988, 146, 185-186.
21. Cotton, R.; Giles, M. G.; Miller, L.; Shaw, J. S.; Timms, D. ICI174864: A Highly Selective Antagonist for the Opioid δ-Receptor. Eur. J. Pharmacol. 1984, 97, 331-332.
22. Portoghese, P. S.; Nagase, H.; MaloneyHuss, K. E.; Lin, C.-E.; Takemori, A. E. Role of Spacer and Address Components in Peptidomimetic i Opioid Receptor Antagonists Related to Naltrindole (NTI). J. Med. Chem. 1991, 34, 1715-1720.
23. Sofuoglu, M.; Portoghese, P. S.; Takemori, A. E. Differential Antagonism of δ Opioid Agonists by Naltrindole (NTI) and its Benzofuran Analog (NTB) in Mice: Evidence for 5 Opioid Receptor Subtypes. J. Pharmacol. Exp. Ther. In press.
24. Audigier, Y.; Mazarguil, H.; Gout, R.; Cros, J. Structure-Activity Relationship of Enkephalin Analogs at Opiate and Enkephalin Receptors: Correlation with Analgesia. Eur. J. Pharmacol. 1980, 63, 35-46.
25. Burgen, A. S. V.; Roberts, G. C. K.; Feeny, J. Binding of Flexible Ligands to Macromolecules. Nature 1975, 253, 753-755.
26. Schiller, P. Conformational Analysis of Enkephalin and Conformation-Activity Relationships. In The Peptides; Udenfriend, S., Meienhofer, J., Eds.; Academic Press; New York, 1984; Vol. 6, pp 219-268.
27. Yoneda, S.; Kitsamura, K.; Doi, M.; Inoue, M.; Ishida, T. Importance of Folded Monomer and Extended Antiparallel Dimer Structures as Enkephalin Active Conformation. FEBS Lett. 1988, 239, 271-275.
28. 8]-Enkephalins. Biochem. J. 1988, 255, 621-628.
29. 1H 400-MHz NMR Study and Theoretical Calculations. Biochemistry 1989, 28, 7392-7400.